19. Шилова Е.С., Боровик Н.В., Попова П.В., Ярмолинская М.И. Диагностика и лечение субклинического гипотиреоза при планировании и во время беременности: современный подход к проблеме // Проблемы Эндокринологии. 2020; 66(6): 65–73. https://doi.org/10.14341/probl12687.
20. Männistö T., Mendola P., Grewal J., Xie Y., Chen Z., Laughon S.K. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort // J Clin Endocrinol Metab. 2013 Jul; 98(7): 2725–33. doi: 10.1210/jc.2012-4233.
21. Poppe K., Bisschop P., Fugazzola L., Minziori G., Unuane D., Weghofer A.: 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction // Eur Thyroid J. 2020; 9: 281–295. doi: 10.1159/000512790.
22. Kahaly G.J., Bartalena L., Hegedüs L., Leenhardt L., Poppe K., Pearce S.H. 2018 European Thyroid Association Guideline for the Management of Graves // Hyperthyroidism. Eur Thyroid J. 2018 Aug; 7(4): 167–186. doi: 10.1159/000490384.
23. Lee S.Y., Pearce E.N. Testing, Monitoring, and Treatment of Thyroid Dysfunction in Pregnancy // J Clin Endocrinol Metab. 2021 Mar 8; 106(3): 883–892. doi: 10.1210/clinem/dgaa945.
24. Luo J., Wang X., Yuan L., Guo L. Association of thyroid disorders with gestational diabetes mellitus: a meta-analysis // Endocrine. 2021 May 13. doi: 10.1007/s12020-021-02712-2.
25. Sheehan P.M., Nankervis A., Araujo Júnior E., Da Silva Costa F. Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis // J Clin Endocrinol Metab. 2015 Nov; 100(11): 4325–31. doi: 10.1210/jc.2015-3074.
26. Coomarasamy A., Devall A.J., Brosens J.J., Quenby S., Stephenson M.D., Sierra S., Christiansen O.B., Small R., Brewin J., Roberts T.E., Dhillon-Smith R., Harb H., Noordali H., Papadopoulou A., Eapen A., Prior M., Di Renzo G.C., Hinshaw K., Mol B.W., Lumsden M.A., Khalaf Y., Shennan A., Goddijn M., van Wely M., Al-Memar M., Bennett P., Bourne T., Rai R., Regan L., Gallos I.D. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence // Am J Obstet Gynecol. 2020 Aug; 223(2): 167–176. doi: 10.1016/j.ajog.2019.12.006.
27. Lee H.J., Park T.C., Kim J.H., Norwitz E., Lee B. The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis. Biomed Res Int. 2017; 2017: 3616875. doi: 10.1155/2017/3616875.
28. Mirza F.G., Patki A., Pexman-Fieth C. Dydrogesterone use in early pregnancy // Gynecol Endocrinol. 2016; 32(2): 97–106. doi: 10.3109/09513590.2015.1121982.
29. Springer D., Jiskra J., Limanova Z., Zima T., Potlukova E. Thyroid in pregnancy: From physiology to screening // Crit Rev Clin Lab Sci. 2017 Mar; 54(2): 102–116. doi: 10.1080/10408363.2016.1269309.
30. Moon H.W., Chung H.J., Park C.M., Hur M., Yun Y.M. Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women // Ann Lab Med. 2015 Mar; 35(2): 198–204. doi: 10.3343/alm.2015.35.2.198.
31. Quinn F.A., Gridasov G.N., Vdovenko S.A., Krasnova N.A., Vodopianova N.V., Epiphanova M.A., Schulten M. Prevalence of abnormal thyroid stimulating hormone and thyroid peroxidase antibody-positive results in a population of pregnant women in the Samara region of the Russian Federation // Clin Chem Lab Med. 2005; 43(11): 1223–6. doi: 10.1515/CCLM.2005.212.
32. Anckaert E., Poppe K., Van Uytfanghe K., Schiettecatte J., Foulon W., Thienpont L.M. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta. 2010 Sep 6; 411(17–18): 1348–53.
33. Lee R.H., Spencer C.A., Mestman J.H., Miller E.A., Petrovic I., Braverman L.E., Goodwin T.M. Free Т4 immunoassays are flawed during pregnancy // Am J Obstet Gynecol. 2009 Mar; 200(3): 260.e1–6. doi: 10.1016/j.ajog.2008.10.042.
34. Pramanik S., Mukhopadhyay P., Ghosh S. Total Т4 rise in pregnancy: a relook? Thyroid Res. 2020 Jul 31; 13: 14. doi: 10.1186/s13044-020-00088-5.
35. Долгушина Н.В., Артымук Н.В., Белокриницкая Т.Е. и др. Клинические рекомендации Российского общества акушеров-гинекологов. Нормальная беременность. 2019. 88 c. Доступ по ссылке: https://minzdravao.ru/sites/default/files/2020/1/normalnaya_beremennost.pdf. Ссылка активна на 25.07.21 г.
36. Nazarpour S., Ramezani Tehrani F., Simbar M., Tohidi M., Minooee S., Rahmati M., Azizi F. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. J Clin Endocrinol Metab. 2018 Mar 1; 103(3): 926–935. doi: 10.1210/jc.2017-01850.
37. Kobaly K., Mandel S.J. Hyperthyroidism and Pregnancy. Endocrinol Metab Clin North Am. 2019 Sep; 48(3): 533–545. doi: 10.1016/j.ecl.2019.05.002.
38. Andersen S.L., Knøsgaard L. Management of thyrotoxicosis during pregnancy. Best Pract Res Clin Endocrinol Metab. 2020 Jul; 34(4): 101414. doi: 10.1016/j.beem.2020.101414.
39. Sarkar S., Bischoff L.A. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period. Semin Reprod Med. 2016 Nov; 34(6): 317–322. doi: 10.1055/s-0036-1593489.